Correction: TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
[This corrects the article DOI: 10.1371/journal.pone.0289535.].
Saved in:
| Main Authors: | Tayebeh Cheraghi-Shavi, Razieh Jalal, Zarrin Minuchehr, Frouzandeh Mahjoubi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0322319 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
by: Tayebeh Cheraghi-Shavi, et al.
Published: (2023-01-01) -
Investigating the cytotoxic effect of aqueous extract of Peganum harmala on oxaliplatin-resistant HCT116 cell line and evaluating BAX gene expression
by: Zahra Salimizadeh, et al.
Published: (2025-03-01) -
FXYD2 marks and regulates maturity of β cells via ion channel-mediated signal transduction
by: Clarissa Tacto, et al.
Published: (2025-06-01) -
Macrophage response to fibrin structure mediated by Tgm2-dependent mitochondrial mechanosensing
by: Bicong Gao, et al.
Published: (2025-08-01) -
Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer
by: Reio Ueta, et al.
Published: (2025-07-01)